ArticleJournal of advanced research2026
A DNA triangular prism scaffold-guided directionally-controlled derailment-free DNAzyme walker.
Article in Journal of advanced research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionDeoxyribozyme (DNAzyme) with RNA cleavage activity, including a DNAzyme walker, has been extensively explored as the tool for cancer diagnosis and therapy due to its excellent programmability, stability, and activity. However, the precise control over the directionality and progressivity of molecular movement towards its predetermined destination remains a formidable challenge.
objectivesWe aim to construct a three-dimensional DNA walker capable of addressing the uncertainty of motion direction because of the deviation from the predesignated track in uniform solutions.
methodsThe cleavage sequence of substrates by DNAzyme was explored through gel electrophoresis analysis .
resultsGel electrophoresis analyses show that DNAzyme cleaves the substrates in a sequential manner and preferentially digests the ones in the shortest spatial distance regardless of their nature, indicating a distance-dependent cleavage process. Moreover, the substrate stands freely moving in a homogenous solution (not confined onto DNA scaffold) cannot be cleaved, implying that the derailment of DNAzmye walker from the tri-prism scaffold is completely circumvented. When the adjacent substrates were removed to leave the vacant sites, the cleavage order of substrates is changed, indicating that the controllability of cleavage behavior of DNAzyme is realized.
conclusionDNA triangular prism-controlled DNAzyme walker circumvents the intractable derailment event and has several advantages, such as low cost, programmability, high cleavage specificity and directional controllability, showing great potential applications in biosensing, cancer, diagnosis and therapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.